No annual revenue total was found in MICROBOT MEDICAL INC.'s SEC filings.
Microbot Medical Inc. (MBOT) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. Free cash flow was -$13.1 million. As of Jun 30, 2026 it held $67.4 million in cash and investments and $876,000 in total debt.
Revenue
—
Net income (TTM)
$-16.34M
-28.6% vs year-ago TTM
Operating cash flow (TTM)
$-17.64M
-78.2% vs year-ago TTM
Free cash flow (TTM)
$-17.93M
-80.6% vs year-ago TTM
EPS (TTM)
$-0.26
+47.9% vs year-ago TTM
Dividend per share
None
Shares outstanding
67.16M
+93.3% vs prior year
Net cash
$66.49M
as of Jun 30, 2026
Operating margin
—
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- MBOT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Hingham, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 883975
- Former names
- Microbot Medical Inc. (until Nov 3, 2026); STEMCELLS INC (until Nov 15, 2016); CYTOTHERAPEUTICS INC/DE (until May 15, 2000)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$14.7M | -$11.6M | -$9.9M | -$13.3M | -$11.4M |
| Net income | -$13.1M | -$11.4M | -$10.7M | -$13.2M | -$11.3M |
| Diluted EPS | -$0.29 | -$0.73 | -$1.05 | — | — |
| Operating cash flow | -$13.0M | -$8.8M | -$8.5M | -$11.5M | -$9.4M |
| Free cash flow | -$13.1M | -$8.9M | -$8.6M | -$11.6M | -$9.4M |
| Total assets | $81.5M | $6.0M | $8.3M | $9.5M | $16.8M |
| Total liabilities | $4.0M | $2.5M | $3.8M | $2.2M | $2.4M |
| Stockholders' equity | $77.6M | $3.5M | $4.5M | $7.3M | $14.4M |
| Cash and investments | $78.6M | $5.5M | $6.4M | $8.2M | $15.5M |
| Total debt | $865,000 | $111,000 | $231,000 | $462,000 | $680,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Nov 3, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 27, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 23, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 20, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 6, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 28, 2026 | Sep 25, 2026 |
All 1004 Microbot Medical Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.